查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1468007

富血小板血浆市场：按来源类型、应用划分 - 2024-2030 年全球预测

Platelet Rich Plasma Market by Source Type (Allogenic, Autologous, Homologous), Application (Cosmetic Surgery, General Surgery, Neurosurgery) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

富血小板血浆市场规模预计2023年为3.8163亿美元，2024年达到4.3086亿美元，预计2030年将达到8.4854亿美元，复合年增长率为12.09%。

富血小板血浆，也称为PRP，是从富含血小板的全血中获得的浓缩血浆。 PRP 是透过离心患者的血液样本来製备的，导致血小板浓度高于基准值。 PRP 的治疗用途因其增强身体自然癒合过程的潜力而受到欢迎。 PRP可应用于多种医学领域，包括整形外科、牙科、运动医学、创伤治疗以及快速发展的美容医学领域。由于对微创治疗的需求增加、运动伤害和整形外科疾病盛行率上升以及寻求美容和抗老化治疗的人口老化，对富含血小板的血浆产品和治疗的需求正在迅速增加。然而，需要更高品质的随机对照试验来证明对各种适应症的疗效，且PRP治疗的高成本限制了患者对富血小板血浆产品的接受和治疗方法的获取可能受到限制。儘管如此，技术创新正在进行中，以提高 PRP 治疗的有效性、安全性和便利性，并有望为 PRP 治疗的普及做出贡献。此外，与学术机构合作产生检验应用所需的可靠临床资料将支持未来几年 PRP 治疗的采用。

主要市场统计
基准年[2023] 3.8163 亿美元
预测年份 [2024] 43086万美元
预测年份 [2030] 84854万美元
复合年增长率（%） 12.09%

来源类型安全性有利于自体 PRP

同种异体 PRP 是指取自捐赠者而非接受治疗的患者的富含血小板的血浆。当患者无法捐赠足够的血小板或自体 PRP 有副作用风险时，通常会使用自体 PRP。同种异体 PRP 必须经过严格的测试，以筛检病原体并确认与接受者的相容性。关于偏好，当自体 PRP 不可行或有疾病传播风险时，指定同种异体 PRP。由于自体PRP源自于患者的血液，因此免疫抗原性反应和疾病传播的风险大大降低。它是最常见的 PRP型态，因为它非常安全。自体 PRP 通常是需要 PRP 治疗整形外科损伤或整容手术的患者的首选。同种异体PRP是指以不同于其在体内自然功能的方式使用的富含血小板的血浆，或提供给来源供体以外的个人使用，同时仍遵循相容性的概念。同种异体 PRP 的使用相对不常见且非常特殊。同种异体 PRP 适合适合移植但不适合约种异体和自体 PRP 选项的患者。

PRP 治疗在应用整形外科的广泛应用

富含血小板的血浆广泛用于整容手术，以促进皮肤再生和癒合。富含血小板的血浆中含有的生长因子浓度可刺激胶原蛋白的产生，可用于拉皮、痤疮疤痕和脱髮治疗等手术。在一般外科手术中，PRP 可以改善创伤治疗、管理术后切口并降低感染疾病风险。普通外科手术中基于需求的偏好受到缩短恢復时间和增强癒合能力的潜力的影响。神经外科中的 PRP 用于涉及脊椎和神经组织的手术，以帮助减少发炎并促进康復。神经外科的关键性质以及快速有效癒合、最小化疤痕和纤维化的重要性创造了对 PRP 治疗的需求。 PRP广泛应用于整形外科，尤其是肌腱损伤、急性韧带损伤、肌肉损伤和关节置换术的治疗。老化人口中肌肉骨骼疾病的增加正在影响整形外科治疗中对 PRP 的需求。

区域洞察

由于对先进医疗保健和运动医学的重视、寻求肌肉骨骼疾病再生治疗的老龄化人口以及寻求快速康復解决方案的运动员集中，美洲的富血小板血浆市场正在迅速开拓。美洲客户的购买行为青睐创新和微创治疗方法。在欧盟（EU），PRP治疗的监管地位已经统一，研究活动也不断增加。强大的医疗基础设施和客户对高品质、规范治疗的偏好推动了对 PRP 治疗的需求。在中东，在寻求高品质医疗服务的富人的支持下，包括 PRP 治疗在内的美容医疗市场正在快速成长。相较之下，非洲PRP市场正处于起步阶段，主要受到医疗保健设施逐渐改善和治疗机会增加的推动。亚太地区正迅速崛起为重要的 PRP 产品市场，其特征是人口众多且新兴市场开拓迅速。由于可支配收入的增加和医疗旅游业的增加，新兴国家 PRP 疗法的采用率显着增加。在整个亚太地区，客户的购买模式正在不断变化，人们越来越重视先进的治疗方法，并且越来越愿意投资健康和保健。

FPNV定位矩阵

FPNV定位矩阵对于评估富血小板血浆市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对富血小板血浆市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.富血小板血浆市场的市场规模与预测是多少？

2.在富血小板血浆市场预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.富血小板血浆市场的技术趋势和法规结构是什么？

4.富血小板血浆市场主要供应商的市场占有率为何？

5. 进入富血小板血浆市场合适的型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球与运动相关的伤害呈上升趋势
      • 在肌肉骨骼和整形外科疾病治疗的潜在应用
      • 增加在整容手术和自然癒合过程中的使用
    • 抑制因素
      • 富血小板血浆治疗效果的不确定性
    • 机会
      • 再生医学的新应用
      • 正在进行的富含血小板血浆衍生生物活性分子的研究和开发活动
    • 任务
      • 富血小板血浆产品的临床试验和报销政策有限
  • 市场区隔分析
    • 来源类型：由于安全性，自我 PRP 是首选
    • 应用：PRP 治疗在整形外科应用的广泛应用
  • 市场趋势分析
  • 俄罗斯-乌克兰衝突的累积影响
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法规结构分析
  • 客户客製化

第六章依来源类型分類的富血小板血浆市场

  • 同种异体的
  • 自体移植
  • 相同的

第七章富血小板血浆市场：依应用分类

  • 整容手术
  • 一般外科
  • 神经外科
  • 整形外科

第八章美洲富血小板血浆市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太富血小板血浆市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲富血小板血浆市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Hairline International推出超音波PRP，最先进的毛髮再生疗法
    • Royal Biologics 宣布 BIOINCYTE PRFM 在美国商业上市

第12章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-035AB9C0DA84

[180 Pages Report] The Platelet Rich Plasma Market size was estimated at USD 381.63 million in 2023 and expected to reach USD 430.86 million in 2024, at a CAGR 12.09% to reach USD 848.54 million by 2030.

Platelet-rich plasma, referred to as PRP, is a concentrated form of plasma derived from whole blood rich in platelets. PRP is prepared by centrifuging a sample of the patient's blood, resulting in a platelet concentration above baseline values. The therapeutic use of PRP has gained popularity due to its potential to augment the body's innate healing process. PRP can be applied in various medical fields, including orthopedics, dentistry, sports medicine, wound healing, and the burgeoning field of aesthetic medicine. Increasing demand for minimally invasive treatments, a rise in the prevalence of sports injuries and orthopedic conditions, and an aging population seeking cosmetic and anti-aging treatments have proliferated the need for platelet rich plasma products and treatments. However, the need for more high-quality, randomized controlled trials to prove its efficacy for various indications and the high cost of PRP therapy can limit patient access to platelet rich plasma products and treatments. Nevertheless, the ongoing technological innovations to improve PRP treatments' efficacy, safety, and convenience are expected to contribute to adopting PRP treatments. Moreover, collaborative efforts with academic institutions to produce the robust clinical data necessary to validate applications encourage the adoption of PRP treatments in the coming years.

KEY MARKET STATISTICS
Base Year [2023] USD 381.63 million
Estimated Year [2024] USD 430.86 million
Forecast Year [2030] USD 848.54 million
CAGR (%) 12.09%

Source Type: Preference for Autologous PRP due to its safety profile

Allogenic PRP refers to platelet-rich plasma harvested from a donor rather than the treated patient. Allogenic PRP is often used in cases where the patient is unable to provide a sufficient quantity of platelets or is at risk of adverse reactions from autologous PRP. Allogenic PRP needs to undergo rigorous testing to screen for pathogens and ensure compatibility with the recipient. Regarding preferences, allogenic PRP is specified when autologous PRP is not an option or when there's a risk of disease transmission. Autologous PRP is derived from the patient's blood, significantly reducing the risk of immunogenic reactions or disease transmission. This is the most common form of PRP due to its safety profile. Autologous PRP is typically preferred for patients who require PRP treatments for orthopedic injuries and cosmetic procedures. Homologous PRP refers to platelet-rich plasma that is used differently than its natural function within the body or donated for use in an individual other than the source donor, still following the concept of compatibility. Homologous PRP's usage is relatively less common and highly specific. Homologous PRP is selected for patients whose conditions align with the transplant compatibility and when allogenic and autologous options are less suitable.

Application: Extensive use of PRP treatments in orthopedic applications

Platelet rich plasma is extensively used in cosmetic surgery to promote skin rejuvenation and healing. The concentration of growth factors in platelet rich plasma can stimulate collagen production and be used for procedures such as facelifts, acne scars, and hair loss treatment. In general surgery, PRP can improve wound healing, manage incisions after surgery, and reduce the risk of infections. The need-based preference in general surgery is impacted by the potential for reduced recovery times and enhanced healing capabilities. PRP in neurosurgery finds its use in procedures involving the spine and nerve tissues, which may help reduce inflammation and facilitate recovery. The critical nature of neurosurgical procedures and the paramount importance of quick and effective healing, with minimal scarring or fibrosis, creates the need for PRP treatments. PRP is widely used in orthopedic surgery, particularly in treating tendon injuries, acute ligament, and muscle injuries, as well as for joint arthroplasty. The corresponding rise in musculoskeletal disorders among the aging population influences the need for PRP in orthopedic treatments.

Regional Insights

The platelet rich plasma market in the Americas is rapidly developing owing to a high emphasis on advancing medical procedures and sports medicine, an aging population seeking regenerative treatments for musculoskeletal conditions, and a high concentration of athletes looking for rapid recovery solutions. Customer purchasing behavior in the Americas favors innovative and minimally invasive therapies. The European Union (EU) presents a unified regulatory landscape for PRP therapies, with increasing research activity. The need for PRP treatment is fueled by a robust healthcare infrastructure and customers' preference for high-quality, regulated treatments. The Middle East has a burgeoning market for cosmetic treatments, including PRP therapies, supported by affluent consumers seeking high-end medical services. In contrast, the African PRP market is more nascent, driven primarily by gradually improving healthcare facilities and the increasing accessibility of treatments. Asia-Pacific is rapidly emerging as a significant PRP product market characterized by its large population and developing healthcare sectors. The emerging economies have shown a considerable increase in the adoption of PRP therapies, driven by rising disposable incomes and increasing medical tourism. Across the Asia Pacific, customer purchasing patterns are evolving, shifting towards valuing advanced treatments and a willingness to invest in health and wellness.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Platelet Rich Plasma Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Platelet Rich Plasma Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Platelet Rich Plasma Market, highlighting leading vendors and their innovative profiles. These include APEX Biologix, Arthrex, Inc., Cascade Medical Wellness & Aesthetics, Celling Biosciences, Inc., Crown Laboratories, Inc., Dr PRP USA LLC, EmCyte Corporation, Estar Technologies Ltd., Exactech, Inc., Factor Medical Inc., Fisher Scientific Company L.L.C., Integrity PRP, Isto Biologics, Johnson & Johnson Services, Inc., Juventix Regenerative Medical, LLC, MDBiologix, PRP Concepts, Inc., Regen Lab SA, ROCKY MOUNTAIN BIOLOGICALS, Sarstedt AG & Co. KG, Stryker Corporation, Terumo BCT, Inc., Terumo Corporation, ThermoGenesis Holdings, Inc., Ycellbio Medical Co., Ltd., and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Platelet Rich Plasma Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Source Type
    • Allogenic
    • Autologous
    • Homologous
  • Application
    • Cosmetic Surgery
    • General Surgery
    • Neurosurgery
    • Orthopedic Surgery
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Platelet Rich Plasma Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Platelet Rich Plasma Market?

3. What are the technology trends and regulatory frameworks in the Platelet Rich Plasma Market?

4. What is the market share of the leading vendors in the Platelet Rich Plasma Market?

5. Which modes and strategic moves are suitable for entering the Platelet Rich Plasma Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing Incidences of Sports-Related Injuries Globally
      • 5.1.1.2. Potential Application in the Treatment of Musculoskeletal Conditions and Orthopedic Disorders
      • 5.1.1.3. Increasing Use in Cosmetic Surgery and for Natural Healing Process
    • 5.1.2. Restraints
      • 5.1.2.1. Uncertainty on Therapeutic Efficacy of Platelet Rich Plasma
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Application in Regenerative Medicine
      • 5.1.3.2. Ongoing Research and Development Activities on Platelet-Rich Plasma Derived Bioactive Molecules
    • 5.1.4. Challenges
      • 5.1.4.1. Limited Availability of Clinical Trials and Reimbursement Policies of Platelet-rich Plasma Products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source Type: Preference for Autologous PRP due to its safety profile
    • 5.2.2. Application: Extensive use of PRP treatments in orthopedic applications
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework Analysis
  • 5.9. Client Customization

6. Platelet Rich Plasma Market, by Source Type

  • 6.1. Introduction
  • 6.2. Allogenic
  • 6.3. Autologous
  • 6.4. Homologous

7. Platelet Rich Plasma Market, by Application

  • 7.1. Introduction
  • 7.2. Cosmetic Surgery
  • 7.3. General Surgery
  • 7.4. Neurosurgery
  • 7.5. Orthopedic Surgery

8. Americas Platelet Rich Plasma Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Platelet Rich Plasma Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Platelet Rich Plasma Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Hairline International Launches Sonicated PRP- a cutting edge Hair Regeneration Therapy
    • 11.3.2. Royal Biologics Announces U.S. Commercial Launch of BIOINCYTE PRFM

12. Competitive Portfolio

  • 12.1. Key Company Profiles
  • 12.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. PLATELET RICH PLASMA MARKET RESEARCH PROCESS
  • FIGURE 2. PLATELET RICH PLASMA MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. PLATELET RICH PLASMA MARKET DYNAMICS
  • FIGURE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 20. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PLATELET RICH PLASMA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL PLATELET RICH PLASMA MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ALLOGENIC, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY HOMOLOGOUS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY COSMETIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY NEUROSURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL PLATELET RICH PLASMA MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 26. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 27. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 28. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 29. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 30. AMERICAS PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 31. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 32. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 33. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. ARGENTINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 36. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 37. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 38. BRAZIL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 39. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 40. CANADA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 41. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 42. CANADA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 43. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 44. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 45. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 46. MEXICO PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 47. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 48. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 49. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 50. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 51. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 52. UNITED STATES PLATELET RICH PLASMA MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 54. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 59. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 60. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 62. AUSTRALIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 63. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. CHINA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. CHINA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 68. INDIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 69. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. INDIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 72. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 73. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 74. INDONESIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 75. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 76. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 77. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 78. JAPAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 79. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 82. MALAYSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 83. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 84. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 86. PHILIPPINES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 87. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 88. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 89. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. SINGAPORE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. SOUTH KOREA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 96. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 97. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 98. TAIWAN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 99. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 100. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 101. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 102. THAILAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 103. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. VIETNAM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA PLATELET RICH PLASMA MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 113. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 114. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 115. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 116. DENMARK PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 117. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 118. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 119. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. EGYPT PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. FINLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 126. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 127. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 128. FRANCE PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 129. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 130. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 131. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. GERMANY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. ISRAEL PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 138. ITALY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 139. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 140. ITALY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. NETHERLANDS PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. NIGERIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 150. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 151. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 152. NORWAY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 153. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 154. POLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 155. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 156. POLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 157. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. QATAR PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. QATAR PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 162. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 163. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. RUSSIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. SAUDI ARABIA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 170. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. SOUTH AFRICA PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 174. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 175. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 176. SPAIN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 177. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. SWEDEN PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 182. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. SWITZERLAND PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 186. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 187. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 188. TURKEY PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2018-2023 (USD MILLION)
  • TABLE 194. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY SOURCE TYPE, 2024-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. UNITED KINGDOM PLATELET RICH PLASMA MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. PLATELET RICH PLASMA MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. PLATELET RICH PLASMA MARKET, FPNV POSITIONING MATRIX, 2023